The NIHR Imperial BRC is now accepting applications for the 2019 ITMAT ‘Push for Impact’ funding call. This scheme aims to accelerate the translation of patient-based discovery research and experimental medicine to deliver clinically focused outputs for the NIHR Imperial BRC and Imperial College Healthcare NHS Trust. With a budget of £600k, this call will […]
Researchers have created new machine learning software that can forecast the survival rates and response to treatments of patients with ovarian cancer. The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne, has been able to predict the prognosis of patients with ovarian cancer more accurately than current methods. […]
Research into nutritional care for patients undergoing haematopoietic cell transplantation resulted in a change of routine clinical practice. Allogeneic haematopoietic cell transplantation is used for treatment of haematologic malignancies, where a patient receives blood-forming stem cells from a donor. In preparation for a transplant, patients receive intensive conditioning, which may include high-dose chemotherapy, with or […]
A new treatment for enlarged prostates can reduce side effects and has the potential to improve the lives of thousands of men. The treatment, which uses steam, has been shown to shrink prostates by 36% and has fewer side effects than current methods. Professor Hashim Ahmed, Consultant Urological Surgeon at Imperial College Healthcare NHS Trust […]
PreventionTherapeutic It takes guts to fight obesity: how hormones could hold the key to sustainable weight loss
Writing in the Imperial Medicine Blog to mark National Obesity Awareness Week, Professor Tricia Tan from the BRC Metabolic Medicine & Endocrinology Theme explained how new research is harnessing the power of hormones to treat obesity more effectively. Obesity has been an issue for centuries. However, it has transformed from a disease that once only touched […]
Harnessing world-leading discovery science and clinical expertise to develop innovative therapeutics, devices and diagnostics for healthcare
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.